Skip to content

Bilateral Uterine Artery Ligation After Intrapartum or Postpartum Hemorrhage on Ovarian Reserve Markers and Pregnancy Outcome

The Effect of Bilateral Uterine Artery Ligation After Intrapartum or Postpartum Hemorrhage on Ovarian Reserve Markers and Pregnancy Outcome

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05647538
Enrollment
120
Registered
2022-12-12
Start date
2020-06-01
Completion date
2022-10-31
Last updated
2023-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bilateral Uterine Artery Ligation, Intrapartum or Postpartum Hemorrhage, Ovarian Reserve Markers, Pregnancy Outcome

Brief summary

The aim of this study is to assess the possible negative effects of uterine artery ligation on ovarian reserve markers and subsequent pregnancy outcomes

Detailed description

One of the most common surgical methods for preserving fertility is uterine artery ligation. It is simple to do and effective at reducing Postpartum hemorrhage after delivery . Additionally, it is rather safe and permits future childbearing for the patients.

Interventions

Bilateral UAL was done 2 cm under the Kerr incision (lower segment transverse). A 2-Vicryl absorbable suture (Ethicon, Neuilly-surSeine, France) was introduced from the anterior to posterior views of the myometrium 2-3 cm medial to the descending part of the uterine vessels within an avascular area in the broad ligament and tied. Following the surgery, the uterine tone and hemorrhage were managed.

Sponsors

Tanta University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 35 Years
Healthy volunteers
No

Inclusion criteria

* 120 females aged from 20 to 35 years old * with Postpartum hemorrhage or intrapartum hemorrhage after cesarean section * did not respond to medical therapy * performed successful bilateral uterine artery ligation for hemorrhage management.

Exclusion criteria

* The presence of male factor or tubal factor. * Hypertension, autoimmune disease, morbid obesity, absence of lactation diabetes millets, vascular disease, smoking or the use of alcohol. * The presence of additional surgery or medical disease. * Detection of a uterine anomaly, history of intrauterine growth restriction in previous pregnancies. * Usage of a hormonal therapy through the research.

Design outcomes

Primary

MeasureTime frameDescription
Ovarian reserve by anti-mullerian hormone24 months after bilateral uterine artery ligation.Anti-mullerian hormone (AMH) level will be determined using a two-sided immunoassay that will be enzymatically amplified (ELISA). AMH was recorded at 6, 12 and 24 months after bilateral uterine artery ligation.

Secondary

MeasureTime frameDescription
Ovarian reserve by follicle stimulating hormone24 months after bilateral uterine artery ligation.follicle stimulating hormone (FSH) level will be determined using a two-sided immunoassay that will be enzymatically amplified (ELISA). FSH was recorded at 6, 12 and 24 months after bilateral uterine artery ligation.
Ovarian reserve by antral follicle counts24 months after bilateral uterine artery ligation.antral follicle counts were recorded at 6, 12 and 24 months after bilateral uterine artery ligation.
Percent of subsequent pregnancy cases24 months after bilateral uterine artery ligation.patients were asked about their desire for pregnancy in the future The data of subsequent pregnancy cases following bilateral UAL primary were recorded and follow-up was done at 6, 12 and 24 months after BUAL.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026